CIA
GILD icon

Capital Investment Advisors’s Gilead Sciences GILD Stock Holding History

Capital Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5M Sell
97,202
-5,464
-5% -$765K 0.2% 98
2025
Q4 		$12.6M Sell
102,666
-3,573
-3% -$434K 0.19% 102
2025
Q3 		$11.8M Sell
106,239
-251,900
-70% -$28.6M 0.19% 97
2025
Q2 		$39.7M Buy
358,139
+5,133
+1% +$546K 0.71% 43
2025
Q1 		$39.6M Sell
353,006
-34,486
-9% -$3.56M 0.77% 37
2024
Q4 		$35.8M Buy
387,492
+9,791
+3% +$882K 0.73% 39
2024
Q3 		$31.7M Buy
377,701
+36,838
+11% +$2.81M 0.65% 47
2024
Q2 		$23.4M Buy
340,863
+10,211
+3% +$681K 0.53% 57
2024
Q1 		$24.2M Sell
330,652
-8,215
-2% -$632K 0.56% 56
2023
Q4 		$27.5M Buy
338,867
+8,377
+3% +$652K 0.69% 40
2023
Q3 		$24.8M Buy
330,490
+25,022
+8% +$1.92M 0.69% 39
2023
Q2 		$23.5M Buy
305,468
+16,050
+6% +$1.28M 0.72% 38
2023
Q1 		$24M Sell
289,418
-10,023
-3% -$830K 0.71% 40
2022
Q4 		$25.7M Buy
299,441
+13,118
+5% +$1.04M 0.78% 38
2022
Q3 		$17.7M Buy
286,323
+22,213
+8% +$1.4M 0.61% 44
2022
Q2 		$16.3M Buy
264,110
+21,732
+9% +$1.35M 0.54% 49
2022
Q1 		$14.4M Sell
242,378
-6,285
-3% -$402K 0.44% 55
2021
Q4 		$18.1M Buy
248,663
+7,023
+3% +$484K 0.55% 48
2021
Q3 		$16.9M Buy
241,640
+20,818
+9% +$1.46M 0.57% 44
2021
Q2 		$15.2M Buy
220,822
+12,587
+6% +$840K 0.52% 49
2021
Q1 		$13.5M Buy
208,235
+11,985
+6% +$773K 0.51% 47
2020
Q4 		$11.4M Buy
196,250
+3,720
+2% +$224K 0.48% 53
2020
Q3 		$12.2M Buy
192,530
+170,334
+767% +$11.8M 0.58% 46
2020
Q2 		$1.71M Buy
22,196
+8,143
+58% +$624K 0.09% 153
2020
Q1 		$1.05M Sell
14,053
-613
-4% -$42.4K 0.07% 187
2019
Q4 		$953K Sell
14,666
-1,196
-8% -$77.9K 0.05% 243
2019
Q3 		$1M Sell
15,862
-295
-2% -$19.3K 0.05% 222
2019
Q2 		$1.09M Sell
16,157
-7,375
-31% -$485K 0.06% 214
2019
Q1 		$1.53M Sell
23,532
-4,715
-17% -$313K 0.09% 167
2018
Q4 		$1.77M Sell
28,247
-3,048
-10% -$213K 0.12% 144
2018
Q3 		$2.42M Sell
31,295
-1,330
-4% -$100K 0.14% 122
2018
Q2 		$2.31M Sell
32,625
-220
-0.7% -$15.5K 0.14% 122
2018
Q1 		$2.48M Buy
32,845
+680
+2% +$54.1K 0.16% 123
2017
Q4 		$2.3M Buy
32,165
+66
+0.2% +$5.01K 0.15% 130
2017
Q3 		$2.6M Buy
32,099
+887
+3% +$67.8K 0.18% 120
2017
Q2 		$2.21M Buy
31,212
+6,158
+25% +$410K 0.16% 130
2017
Q1 		$1.7M Buy
25,054
+4,580
+22% +$322K 0.13% 147
2016
Q4 		$1.47M Buy
20,474
+7,176
+54% +$533K 0.12% 154
2016
Q3 		$1.05M Buy
13,298
+2,174
+20% +$177K 0.09% 188
2016
Q2 		$928K Sell
11,124
-809
-7% -$71.8K 0.09% 197
2016
Q1 		$1.1M Buy
11,933
+266
+2% +$24K 0.11% 163
2015
Q4 		$1.18M Buy
11,667
+5,617
+93% +$584K 0.12% 153
2015
Q3 		$594K Buy
6,050
+1,085
+22% +$121K 0.07% 211
2015
Q2 		$581K Buy
4,965
+1,650
+50% +$180K 0.06% 225
2015
Q1 		$325K Buy
3,315
+420
+15% +$42.6K 0.03% 303
2014
Q4 		$273K Hold
2,895
– – 0.03% 322
2014
Q3 		$308K Hold
2,895
– – 0.04% 295
2014
Q2 		$240K Sell
2,895
-100
-3% -$7.78K 0.03% 329
2014
Q1 		$212K Hold
2,995
– – 0.03% 355
2013
Q4 		$225K Buy
+2,995
New +$209K 0.03% 340

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital Investment Advisors's GILD Position: Q1 2026 in Review

Capital Investment Advisors reduced its Gilead Sciences (GILD) stake by 5.3% in Q1 2026, selling an estimated $765K and leaving 97,202 shares worth $13.5M. The position accounts for 0.2% of the portfolio, ranked #98.

Capital Investment Advisors first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $39.7M in Q2 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Capital Investment Advisors held 97,202 shares of Gilead Sciences worth $13.5M as of Q1 2026.
  • Capital Investment Advisors sold 5,464 Gilead Sciences shares in Q1 2026, an estimated $765K.
  • Gilead Sciences made up 0.2% of Capital Investment Advisors's portfolio in Q1 2026, its #98 holding.
  • Capital Investment Advisors first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • Capital Investment Advisors's Gilead Sciences position peaked at $39.7M in Q2 2025.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.